Efficacy of Tripterygium glycosides in immune-mediated kidney diseases as a immunomodulation drug in combination with conventional immunosuppressive agents: a systematic review and meta-analysis of randomized controlled trials

Efficacy of Tripterygium glycosides in immune-mediated kidney diseases as a immunomodulation drug in combination with conventional immunosuppressive agents: a systematic review and meta-analysis of randomized controlled trials

BackgroundImmune-mediated kidney diseases involve the immune system attacking the kidneys, resulting in damage and dysfunction. Tripterygium glycosides (TG) are known for their strong immunosuppressive and anti-inflammatory effects and are commonly used alongside traditional immunosuppressive agents...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yaotan Li, Jinyi Hou, Xiaochang Wu, Chang Liu, Mengqi Zhou, Shijia Lin, Weijing Liu, Yaoxian Wang, Huijuan Zheng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Pharmacology
Subjects:	Tripterygium glycosides immune-mediated kidney diseases randomized controlled trials immunosuppressive agents meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1525482/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Meta-analysis of the efficacy and safety of tripterygium glycosides versus RAAS blockers in the treatment of diabetic kidney disease
by: ZHU Guo-shuang, et al.
Published: (2019-01-01)

Research on nanoemulsion for increasing effects and reducing toxicity of Tripterygium wilfordii polyglycosides
by: HE Xin, et al.
Published: (2008-05-01)

The emerging role of mitochondria in the pharmacological and toxicological effects of Tripterygium wilfordii Hook F: functions, targets and new therapeutic applications
by: Zhonghao Liu, et al.
Published: (2025-07-01)

Pharmacological aspects of acute treatment glycoside intoxication
by: M. I. Sperling, et al.
Published: (2021-08-01)

SPIROSTAN GLYCOSIDES FROM TRIBULUS TERRESTRIS
by: Nguyen Van Quoc*, et al.
Published: (2025-06-01)

The high utilization of human milk oligosaccharides with glycoside hydrolase family exsH gene in Akkermansia species
by: Xiaobao Xie, et al.
Published: (2025-06-01)

N-Glycosides of indigo, indirubin, and isoindigo: blue, red, and yellow sugars and their cancerostatic activity
by: Peter Langer
Published: (2024-11-01)

The Thermal Properties of Gliadins and Glutenins Fortified with Flavonoids and Their Glycosides Studied via Thermogravimetry (TGA) and Differential Scanning Calorimetry (DSC)
by: Magdalena Krekora, et al.
Published: (2025-06-01)

Distribution and processing characteristics of two acylated flavonol glycosides in Camellia sinensis
by: HUANG Yanmei, et al.
Published: (2022-10-01)

ez-CAZy a reference annotation database for linking glycoside hydrolase sequence to enzymatic activity
by: Daniel S. Erdody, et al.
Published: (2025-07-01)

UGT708S6 from Dendrobium catenatum, catalyzes the formation of flavonoid C-glycosides
by: Luyao Yu, et al.
Published: (2024-11-01)

Effect of Bay leaf (Laurus nobilis L.) and its isolated (flavonoids and glycosides) on the lipids profile in the local Iraqi female rabbits
by: Othman Rashid AL-Samarrai, et al.
Published: (2023-01-01)

Acoustical spectroscopy of carbohydrate aqueous solutions: saccharides; alkyl glycosides; cyclodextrins. Part II. Association and Complexation
by: Udo KAATZE
Published: (2013-11-01)

Comparative effects of raw and processed cistanche glycosides on the HPT axis and gut microbiota in a rat model of kidney-yang deficiency
by: Xiaoqing Shen, et al.
Published: (2025-07-01)

AN ACTION OF EXOGENOUS STEROIDAL GLYCOSIDE ON EXHIBITION OF INBREEDING DEPRESSION IN RED BEET PLANTS UNDER PROTECTED CULTIVATION TECHNOLOGY
by: E. G. Kozar, et al.
Published: (2017-07-01)

Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis
by: Xinyi Lyu, et al.
Published: (2025-03-01)

Research progress of the immunosuppressive tumor microenvironment in multiple myeloma
by: Yue WANG, et al.
Published: (2025-08-01)

Multi-target mechanism of Tripteryguim wilfordii Hook for treatment of ankylosing spondylitis based on network pharmacology and molecular docking
by: Jing Zhang, et al.
Published: (2021-01-01)

The Urate-Lowering Effects and Renal Protective Activity of Iridoid Glycosides from <i>Paederia foetida</i> in Rats with Hyperuricemia-Induced Kidney Injury: A Pharmacological and Molecular Docking Study
by: Haifeng Zhou, et al.
Published: (2025-07-01)

Total paeony glycoside alleviates brain injury of rat models developed by cerebral ischemia-reperfusion
by: PENG Yingjuan, LI Zhiying, SUN Linlin, YANG Huijie, WANG Tiantian, ZHOU Liping
Published: (2025-01-01)

Immunosuppressant management in palliative care: a systematic review
by: Kassandra Maja Birchler, et al.
Published: (2025-07-01)

EXPRESSION OF IMMUNOCORRECTIVE EFFECTS OF PHENOTROPIL AT DIFFERENT TERMS OF INDUCED IMMUNOSUPPRESSION
by: M. A. Samotrueva, et al.
Published: (2014-07-01)

Factors affecting the rate of immunosuppression development in children with HIV infection
by: V. B. Denisenko, et al.
Published: (2022-04-01)

Development and Validation of an Analytical Procedure for Determining Convallatoxin in Medicinal Products Containing Cardiac Glycosides of Lily of the Valley
by: T. A. Golomazova, et al.
Published: (2024-11-01)

Comparative analysis of induction immunosuppressive therapy protocols in renal transplant recipients (retrospective review)
by: Sh. R. Galeev, et al.
Published: (2020-07-01)

Division of the large and multifunctional glycoside hydrolase family 2: high functional specificity and biochemical assays in the uncharacterized subfamilies
by: Annie Lebreton, et al.
Published: (2025-07-01)

Total Synthesis of Cardenolides Acospectoside A and Acovenoside B
by: Benzhang Liu, et al.
Published: (2025-05-01)

CERTAIN MECHANISMS OF SECONDARY IMMUNOSUPPRESSION UNDER CHRONISATION OF GEOHELMINTHIASIS
by: E. A. Grishina, et al.
Published: (2016-12-01)

WCN24-2086 Demethylzeylasteral serum concentration was proved as Tripterygium Glycosides effects Biomarker on diabetic nephropathy treatment
by: MAO YONGHUI, et al.
Published: (2024-04-01)

Research trends and topics on sepsis immunosuppression: a bibliometric and visual analysis of global research from 2004 to 2024
by: Ji Yin, et al.
Published: (2025-08-01)

VPS25 Promotes an Immunosuppressive Microenvironment in Head and Neck Squamous Cell Carcinoma
by: Li-Guo Chen, et al.
Published: (2025-02-01)

Purified Cornel Iridoid Glycosides Attenuated Oxidative Stress Induced by Cerebral Ischemia-Reperfusion Injury via Morroniside and Loganin Targeting Nrf2/NQO-1/HO-1 Signaling Pathway
by: Zhaoyang Wang, et al.
Published: (2025-08-01)

Immunosuppression, tonsillectomy and remissions in high-risk IgA-nephropathy
by: Zinaida Sh. Kochoyan, et al.
Published: (2024-01-01)

Listeriosis as one of the reasons of adverse outcomes in patients with immunosuppressive conditions
by: Ya. M. Eremushkina, et al.
Published: (2021-06-01)

Ginkgolic acid inhibits CD8+ T cell activation and induces ferroptosis by lactate dehydrogenase A to exert immunosuppressive effect
by: Sai Zhang, et al.
Published: (2025-07-01)

The basic principles of immunosuppressive therapy after kidney transplantation
by: D. N. Suslov
Published: (2018-03-01)

Immunosuppressants in modern approaches to treatment of inflammatory bowel diseases
by: O. B. Schukina, et al.
Published: (2013-05-01)

A population-based analysis of immunosuppression therapy after organ transplantation
by: Franziska Hörbrand, et al.
Published: (2025-05-01)

Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
by: Weiqiang Lu, et al.
Published: (2020-12-01)

Molecular profiling reveals features of clinical immunity and immunosuppression in asymptomatic P. falciparum malaria
by: Stephanie I Studniberg, et al.
Published: (2022-04-01)